Search

everythinglearnresearchcommunity

for

Search:↓

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

The study suggests a possible increase in androgen receptors in patients with frontal fibrosing alopecia, but more research is needed.

Dihydrotestosterone increases arterial stiffness in female mice without changing blood pressure or aortic wall thickness.

The conclusion is to diagnose PCOS with just hyperandrogenism and irregular periods, and treat with lifestyle changes and basic medications.

Hair growth supplements do not reduce the effectiveness of the breast cancer treatment tamoxifen.

Testosterone works in different ways, including direct interaction with its receptor, conversion to other hormones for specific effects on genitalia, hair, bones, and muscle, and changes in body fat and sexual function when low.

Bilateral Orchiectomy effectively reduces the need for anti-androgen medication in most transgender females.

High testosterone increases heart disease risk in women with PCOS.

Finasteride affects prostate development differently in male and female Mongolian gerbils.

Removing a testicular tumor in a dog reduced its aggressive behavior and skin problems.

The runner's bone injuries were linked to untreated Celiac Disease and low energy availability affecting her bone density.

A 31-year-old woman was diagnosed with Complete Androgen Insensitivity Syndrome much later than usual, leading to a call for earlier detection and treatment guidelines.

Women with hair thinning have disrupted steroid hormone levels, but this doesn't often show as other health issues. More research is needed on hormone balance in this condition.

Skin problems in the elderly are unique and may indicate other diseases, involving changes in skin, hair, nails, and increased cancer risk.

Flutamide caused damage to male rat reproductive organs and may affect fertility.

An 86-year-old man with prostate cancer was diagnosed with a rare, low-grade breast cancer and underwent surgery but declined additional hormone therapy.

CK 5/6 expression in breast cancer is linked to negative hormone receptor status and higher tumor grade.

ROR-alpha may increase the growth of certain breast cancer cells by boosting aromatase, which could affect breast cancer prognosis.

Doctors recommend postoperative radiation for male breast cancer, advise against testosterone for vasomotor symptoms post-adrenalectomy, suggest non-hormonal treatments for atrophic vaginitis after mastectomy, note no specific treatment for anticoagulant-induced hair loss, and call for more research on silicosis from silicon carbide exposure.

Ferulic acid may help control menstrual cycle-related epilepsy by affecting female hormones.

Finasteride may cause sexual dysfunction by reducing epinephrine levels.

Estradiol-rich plasma can increase hair density faster and more effectively in male pattern baldness treatment than regular plasma.

Female pattern hair loss is different from male pattern hair loss and has unclear genetic causes.

Dr. Rodney Sinclair uses a detailed grading system to diagnose female pattern hair loss, recommends daily spironolactone and minoxidil for treatment, and believes genetics play a role in the condition.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Spironolactone can cause side effects like irregular bleeding, but lower doses may reduce these effects and still improve hirsutism.

New treatments for male hypogonadism are effective and should be personalized.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Some breast cancer patients on hormonal therapy may develop male or female pattern hair loss, which can sometimes be improved with topical treatments.